The CTC offices are currently closed for refurbishment. Access to trial TMFs and patient records will be limited during this period. We will still be able to receive post during this time, but there may be a small delay in responding to this. Our fax lines may also be subject to disruption. Where possible, please direct all correspondence via email to trial-specific email addresses. We appreciate your patience and understanding.

Due to COVID-19 and current government guidance, UCL CTC staff continue to work remotely with limited access to the office. Please continue to email the trial specific mailbox with any urgent queries. For paper CRF trials, please continue to copy and scan CRFs to the trial inboxes (remove all patient identifiers except Trial Number and Initials) until further notice.

 
Trial Details
Trial status:
Archived
Recruitment start date:
07/04/2006
Funder:
Cancer Research UK
Sponsor:
UCL
Chief Investigator:
Prof Peter Hoskin
Recruitment target:
650
EudraCT number:
Contact details:
ctc.FoRT@ucl.ac.uk
Lay summary:
FoRT
Follicular Radiotherapy Trial - A Phase III multi-centre randomised controlled trial of low dose radiotherapy for follicular lymphoma and marginal zone lymphoma.
Description
Design:
Treatment:
Key inclusion/exclusion criteria:
Duration of recruitment:
Aim

Trial protocols
Trial protocols must not be applied to patients treated outside trials. UCL CTC can only ensure that approved trial investigators are provided with amendments to protocols.
NameVersionCurrent versRelease dateDownload
FoRT Protocol v6.0 01 05 09_05122019_0.pdf6.0 Current
Trial documents
No documents have been currently made available for download
Contact Us
Cancer Research UK & UCL Cancer Trials Centre
University College London
90 Tottenham Court Road
London
W1T 4TJ

View map
Email:
ctc.enquiries@ucl.ac.uk
Telephone:
+44 (0)20 7679 9898 (General CTC Enquiries)
Fax:
020 7679 9899
University College London, Gower Street, London, WC1E 6BT +44 (0)20 7679 2000

Copyright © 2021 UCL | Disclaimer | Freedom of Information | Accessibility | Privacy | Cookies | Contact Us